BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 12963610)

  • 1. Noninfectious endophthalmitis associated with intravitreal triamcinolone injection.
    Roth DB; Chieh J; Spirn MJ; Green SN; Yarian DL; Chaudhry NA
    Arch Ophthalmol; 2003 Sep; 121(9):1279-82. PubMed ID: 12963610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone.
    Yoon SJ; Rhee DY; Marx JL; Blaha GR; Rogers AH; Baumal CR; Reichel E; Duker JS
    Am J Ophthalmol; 2009 Jun; 147(6):1031-6. PubMed ID: 19268893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.
    Jonas JB
    Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hypopyon following intravitreal triamcinolone acetonide injection in a pseudophakic patient.
    Amato JE; Lee DH; Santos BA; Akduman L
    Ocul Immunol Inflamm; 2005; 13(2-3):245-7. PubMed ID: 16019686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sterile endophthalmitis following intravitreal injection of triamcinolone acetonide.
    Wang LC; Yang CM
    Ocul Immunol Inflamm; 2005; 13(4):295-300. PubMed ID: 16159720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal triamcinolone acetonide treatment of macular edema associated with central retinal vein occlusion.
    Goff MJ; Jumper JM; Yang SS; Fu AD; Johnson RN; McDonald HR; Ai E
    Retina; 2006 Oct; 26(8):896-901. PubMed ID: 17031289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Er H; Yilmaz H
    Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal triamcinolone for the treatment of macular edema associated with central retinal vein occlusion.
    Ip MS; Gottlieb JL; Kahana A; Scott IU; Altaweel MM; Blodi BA; Gangnon RE; Puliafito CA
    Arch Ophthalmol; 2004 Aug; 122(8):1131-6. PubMed ID: 15302652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infectious and presumed noninfectious endophthalmitis after intravitreal triamcinolone acetonide injection.
    Nelson ML; Tennant MT; Sivalingam A; Regillo CD; Belmont JB; Martidis A
    Retina; 2003 Oct; 23(5):686-91. PubMed ID: 14574256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
    Hayashi K; Hayashi H
    Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial.
    Sutter FK; Simpson JM; Gillies MC
    Ophthalmology; 2004 Nov; 111(11):2044-9. PubMed ID: 15522370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide for macular oedema owing to retinal vein occlusion.
    Patel PJ; Zaheer I; Karia N
    Eye (Lond); 2008 Jan; 22(1):60-4. PubMed ID: 16902493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infectious and noninfectious endophthalmitis after intravitreal high-dosage triamcinolone acetonide.
    Jonas JB; Kreissig I; Spandau UH; Harder B
    Am J Ophthalmol; 2006 Mar; 141(3):579-80. PubMed ID: 16490517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
    Avitabile T; Longo A; Reibaldi A
    Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endophthalmitis with retinal necrosis following intravitreal triamcinolone acetonide injection.
    Aggermann T; Stolba U; Brunner S; Binder S
    Ophthalmologica; 2006; 220(2):131-3. PubMed ID: 16491037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.
    Sørensen TL; Haamann P; Villumsen J; Larsen M
    Acta Ophthalmol Scand; 2005 Feb; 83(1):67-70. PubMed ID: 15715560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Onset of an outbreak of Bipolaris hawaiiensis fungal endophthalmitis after intravitreal injections of triamcinolone.
    Small KW; Chan CK; Silva-Garcia R; Walsh TJ
    Ophthalmology; 2014 Apr; 121(4):952-8. PubMed ID: 24507858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study on efficacy of a combination therapy of triamcinolone acetonide administration with and without vitrectomy for macular edema associated with branch retinal vein occlusion.
    Hirano Y; Sakurai E; Yoshida M; Ogura Y
    Ophthalmic Res; 2007; 39(4):207-12. PubMed ID: 17596753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.